hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 19:15:42 - browse：73734

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New lesbian bars spark hope amid disappearing LGBTQ+ spaces

explore

WSS

FDA panel signals lack of confidence in Amgen cancer drug data

3 questions for the future of Biden's cancer moonshot

Medical experts exlpore how to eliminate bias in clinical algorithms

A Q&A with the global head of Boehringer Ingelheim's innovation unit

VC firm General Catalyst wants to buy a health system

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

focus

hotspot

knowledge

In age of alternative facts, a scholarly course on calling out crap

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Trump demands the U.S. pay no more for drugs than other countries … again

Chemotherapy drug shortage eases slightly but still widespread

Medical leaders decry Supreme Court decision on affirmative action

AI can decode, harness the power of the humane immune system

Trump demands the U.S. pay no more for drugs than other countries … again

Why do we get seasonal allergies?

ChatGPT in medicine: STAT answers readers' burning questions

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Wikipedia

Was Amgen transparent enough on FDA's concern on cancer drug?

The strange history of BMI, the body mass index

Physician executives need more than on

VC firm General Catalyst wants to buy a health system

ADA: All diabetes patients should be screened for liver condition

GOP inquiry over gain

explore

Wikipedia

entertainment

hotspot